Back to KROS

WELLS FARGO & COMPANY/MN → KROS

WELLS FARGO & COMPANY/MN KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
9
Latest value
$1.6M
Q3 2026
Peak value
$1.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$667K
Q1 2026$122K
Q1 2026$1.5M
Q1 2026$122K
Q1 2026$1.5M
Q2 2026$166K
Q2 2026$1.5M
Q3 2026$41K
Q3 2026$1.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.6M140.0K——
Q3 2026$41K3.6K——
Q2 2026$1.5M140.0K——
Q2 2026$166K15.5K——
Q1 2026$1.5M140.0K——
Q1 2026$122K11.0K——
Q1 2026$1.5M140.0K——
Q1 2026$122K11.0K——
Q4 2025$667K32.8K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other WELLS FARGO & COMPANY/MN positions

AZN

ASTRAZENECA PLC

$18.9B
AAPL

APPLE INC

$10.8B
MSFT

MICROSOFT CORP

$9.9B
SPY

SPDR S&P 500 ETF TR

$9.6B
AAPL

APPLE INC

$9.4B
MSFT

MICROSOFT CORP

$9.3B
AAPL

APPLE INC

$8.5B
ETHA

ISHARES TR

$8.4B